Global Immunotoxins Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Immunotoxins Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Immunotoxins report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Immunotoxins market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Solid Tumors and Leukemias are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Immunotoxins industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Immunotoxins key manufacturers include Biotest, Celldex Therapeutics, Amgen, Genmab, AREVA Med, Bayer HealthCare, Neurocrine Biosciences, Research Corporation Technologies and CuraGen Corporation, etc. Biotest, Celldex Therapeutics, Amgen are top 3 players and held % sales share in total in 2022.
Immunotoxins can be divided into Anthrax Based Toxins, Diphtheria Toxin (DT) & DT Derivatives, Pseudomonas Exotoxin (PE) & PE Derivatives and Ribosome Inactivating Proteins Based Immunotoxins, etc. Anthrax Based Toxins is the mainstream product in the market, accounting for % sales share globally in 2022.
Immunotoxins is widely used in various fields, such as Solid Tumors and Leukemias, etc. Solid Tumors provides greatest supports to the Immunotoxins industry development. In 2022, global % sales of Immunotoxins went into Solid Tumors filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Immunotoxins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Biotest
Celldex Therapeutics
Amgen
Genmab
AREVA Med
Bayer HealthCare
Neurocrine Biosciences
Research Corporation Technologies
CuraGen Corporation
Genentech
Segment by Type
Anthrax Based Toxins
Diphtheria Toxin (DT) & DT Derivatives
Pseudomonas Exotoxin (PE) & PE Derivatives
Ribosome Inactivating Proteins Based Immunotoxins
Ribonucleases based Immunotoxins
Others
Solid Tumors
Leukemias
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Immunotoxins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Immunotoxins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Immunotoxins industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Immunotoxins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Immunotoxins introduction, etc. Immunotoxins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Immunotoxins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Immunotoxins industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Immunotoxins key manufacturers include Biotest, Celldex Therapeutics, Amgen, Genmab, AREVA Med, Bayer HealthCare, Neurocrine Biosciences, Research Corporation Technologies and CuraGen Corporation, etc. Biotest, Celldex Therapeutics, Amgen are top 3 players and held % sales share in total in 2022.
Immunotoxins can be divided into Anthrax Based Toxins, Diphtheria Toxin (DT) & DT Derivatives, Pseudomonas Exotoxin (PE) & PE Derivatives and Ribosome Inactivating Proteins Based Immunotoxins, etc. Anthrax Based Toxins is the mainstream product in the market, accounting for % sales share globally in 2022.
Immunotoxins is widely used in various fields, such as Solid Tumors and Leukemias, etc. Solid Tumors provides greatest supports to the Immunotoxins industry development. In 2022, global % sales of Immunotoxins went into Solid Tumors filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Immunotoxins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Biotest
Celldex Therapeutics
Amgen
Genmab
AREVA Med
Bayer HealthCare
Neurocrine Biosciences
Research Corporation Technologies
CuraGen Corporation
Genentech
Segment by Type
Anthrax Based Toxins
Diphtheria Toxin (DT) & DT Derivatives
Pseudomonas Exotoxin (PE) & PE Derivatives
Ribosome Inactivating Proteins Based Immunotoxins
Ribonucleases based Immunotoxins
Others
Segment by Application
Solid Tumors
Leukemias
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Immunotoxins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Immunotoxins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Immunotoxins industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Immunotoxins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Immunotoxins introduction, etc. Immunotoxins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Immunotoxins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices